Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

cell cancer

This page shows the latest cell cancer news and features for those working in and with pharma, biotech and healthcare.

Merck reports positive results for Keytruda combination in malignant pleural mesothelioma

Merck reports positive results for Keytruda combination in malignant pleural mesothelioma

Malignant mesothelioma is a type of cancer that starts in the linings of certain parts of the body, with new cases numbering 30, 000 worldwide in 2020. ... Keytruda’s combination with platinum-based chemotherapy has already become a standard of care in

Latest news

More from news
Approximately 1 fully matching, plus 922 partially matching documents found.

Latest Intelligence

  • CAR-T cell therapy in oncology CAR-T cell therapy in oncology

    large B-cell lymphoma, acute lymphoblastic leukaemia and other relapsed/ refractory haematologic cancer. ... It is hypothesised that by genetically engineering lentiviral vectors with cancer cell antigens and in turn, using these to transduce dendritic

  • The promise of precision medicine The promise of precision medicine

    The most promising results seen to date show that genetic information has helped boost the survival rates of those suffering from advanced non-small-cell lung cancer by four to five

  • Successful product commercialisation: what can we learn from the rare disease setting? Successful product commercialisation: what can we learn from the rare disease setting?

    With an increasing number of drug trials in crowded markets such as oncology (for example, in non-small cell lung cancer and multiple myeloma), understanding patient needs is not only critical ... For novel therapies (including medicines aimed at rare

  • Unlocking the potential of precision medicine in oncology Unlocking the potential of precision medicine in oncology

    those living with urothelial carcinoma (UC), the most common type of bladder cancer. ... Targeted therapies. Furthermore, by following a similar trajectory in the treatment of non-small cell lung cancer (NSCLC), where we are studying specific alterations

  • BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches

    One technology that has the potential to advance the field of immuno-oncology is Amgen’s versatile Bispecific T cell Engager or BiTE platform. ... the other is designed to engage with any tumour-specific antigen, for example DLL3 in small-cell lung

More from intelligence
Approximately 0 fully matching, plus 49 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • The heavy toll of COVID-19 on cancer patients

    During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. ... The therapy works predominantly on non-small cell lung cancer. The NHS has also rolled out four chemo-buses which allowed patients to take part in therapy

  • Delphi Technique Virtual Co-creation: A Customer Story

    The client’s main objectives were to:. Determine the current barriers to biomarker testing and biomarker-based treatment for non-small cell lung cancer (NSCLC), including differences in regional access and

  • Bluedog is bursting with new creative and digital talent

    Finally, Victoria William joins Bluedog as a senior account executive. Victoria has an MSc in cancer cell biology and two years’ experience working at an independent creative healthcare agency.

  • Is our health at risk by delaying Dr appointments? Is our health at risk by delaying Dr appointments?

    Nevertheless, a smear test is one of the most crucial appointments we can make, as it is our best chance of protection against developing cervical cancer through detection of cell abnormalities. ... infections. Therefore, cutting down on smoking could

  • OPEN Health OPEN Health

    CRISIS  Action Against Hunger  Cardiac Risk in the Young  NHS Blood Donation  Breast Cancer Research UK  Breast Cancer Research Foundation  Sickle Cell Society  Marie Curie  Bowel Cancer UK  M4RD  Young Enterprise ... Precision medicine with

More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...

Quick links